Cebil (Anadenanthera colubrina)
What Is Cebil?
Cebil is listed botanically as Anadenanthera colubrina, a plant of the Fabaceae family, native to South America. The material in circulation is seed, bark (ethnobotanical) — bark, stripped from stem or trunk. Most people search for it simply as Cebil; suppliers, pharmacopoeias and interaction databases list it as Anadenanthera colubrina, and matching the two is the first step in identifying what is actually in a product. Its character is described as bitter, faintly resinous, which is often how the raw material is checked for quality.
Use of Cebil predates its chemical analysis by a long way: earlier records describe it by season, preparation and the part gathered rather than by any constituent, and that practical knowledge is what later study was measured against. Beyond its practical use it carries cultural associations — tiwanaku-era 'huilca' — trance snuff of Andean priests.
Today most searches for Cebil come from people reading about lung support and eye health, or checking how it sits alongside a medication they already take. The use most often documented in the literature is bark decoction traditional for cough and dysentery, followed by ceremonial visionary use.
How Does Cebil Work?
Cebil works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in seed, bark (ethnobotanical) rather than by one marker molecule.
Traditional practice described Cebil in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.
Published research is sparse, so most of what is documented here comes from traditional use and preliminary laboratory work, and this profile cites 1 source. Reported findings centre on seed: bufotenine, N,N-DMT and 5-MeO-DMT. Where research exists, it examines bark decoction traditional for cough and dysentery and ceremonial visionary use. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into fixed oil and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Cebil is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Cebil is documented as interacting with maois. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Cebil can differ substantially; this is why reference entries specify seed, bark (ethnobotanical) and, where they exist, standardisation markers.